SCHEMBL3571293

SCHEMBL3571293

Cn1c(=O)c(-c2ccc(Cl)cc2Cl)cc2c3cc(C4=NN=C(C(Cl)(Cl)Cl)C4=O)ccc3n(C)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HSD11B1 P28845 5/20 0.36
▸ CNR1 P21554 11/20 0.35
▸ CNR2 P34972 10/20 0.35
▸ GABRA1 P14867 3/20 0.33
▸ ADRA2C P18825 2/20 0.33
▸ SLC6A3 Q01959 2/20 0.33
▸ F2RL3 Q96RI0 1/20 0.33
▸ ADRB3 P13945 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569243 0.87 CNR1 (0.38) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL3568345 0.87 CNR1 (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1337210 0.77 KDM4E (0.37) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1340416 0.77 ALDH1A1 (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL2382190 0.76 F2RL3 (0.46) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1338090 0.76 KDM4E (0.52) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1338074 0.76 L3MBTL1 (0.40) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1339131 0.76 NOTUM (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1339072 0.76 CNR1 (0.38) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL1338674 0.76 F2RL3 (0.37) KDM4EALDH1A1GAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812165-B2 6-substituted pyridoindolone derivatives, production and therapeutic use thereof SANOFI-AVENTIS (FR) 2010-10-12 — — US disclosed
US-20070129365-A1 6-Substituted pyridoindolone derivatives, production and therapeutic use thereof SANOFI-AVENTIS (FR) 2007-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129365-A1 6-Substituted pyridoindolone derivatives, production and therapeutic use thereof PNPO, CYP2D6, DPYD KDM4E 3074/4885ALDH1A1 628/4885GAA 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback